1. Home
  2. FGMC vs CRBU Comparison

FGMC vs CRBU Comparison

Compare FGMC & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGMC
  • CRBU
  • Stock Information
  • Founded
  • FGMC 2023
  • CRBU 2011
  • Country
  • FGMC United States
  • CRBU United States
  • Employees
  • FGMC N/A
  • CRBU N/A
  • Industry
  • FGMC
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • FGMC
  • CRBU Health Care
  • Exchange
  • FGMC NYSE
  • CRBU Nasdaq
  • Market Cap
  • FGMC 101.8M
  • CRBU 93.0M
  • IPO Year
  • FGMC 2025
  • CRBU 2021
  • Fundamental
  • Price
  • FGMC $9.85
  • CRBU $1.63
  • Analyst Decision
  • FGMC
  • CRBU Strong Buy
  • Analyst Count
  • FGMC 0
  • CRBU 4
  • Target Price
  • FGMC N/A
  • CRBU $8.50
  • AVG Volume (30 Days)
  • FGMC 21.6K
  • CRBU 1.9M
  • Earning Date
  • FGMC 01-01-0001
  • CRBU 08-05-2025
  • Dividend Yield
  • FGMC N/A
  • CRBU N/A
  • EPS Growth
  • FGMC N/A
  • CRBU N/A
  • EPS
  • FGMC 0.08
  • CRBU N/A
  • Revenue
  • FGMC N/A
  • CRBU $9,918,000.00
  • Revenue This Year
  • FGMC N/A
  • CRBU $9.52
  • Revenue Next Year
  • FGMC N/A
  • CRBU N/A
  • P/E Ratio
  • FGMC $573.47
  • CRBU N/A
  • Revenue Growth
  • FGMC N/A
  • CRBU N/A
  • 52 Week Low
  • FGMC $9.53
  • CRBU $0.66
  • 52 Week High
  • FGMC $9.90
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • FGMC N/A
  • CRBU 66.57
  • Support Level
  • FGMC N/A
  • CRBU $1.34
  • Resistance Level
  • FGMC N/A
  • CRBU $1.79
  • Average True Range (ATR)
  • FGMC 0.00
  • CRBU 0.12
  • MACD
  • FGMC 0.00
  • CRBU 0.03
  • Stochastic Oscillator
  • FGMC 0.00
  • CRBU 72.84

About FGMC FG MERGER II CORP

FG Merger II Corp is a blank check company, incorporated for the purpose of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (Business Combination).

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: